Skip to Content

GS XJG (Tykerb 250 mg)

Generic Name: lapatinib

Pill imprint GS XJG has been identified as Tykerb 250 mg.

Tykerb is used in the treatment of breast cancer, metastatic; breast cancer and belongs to the drug classes EGFR inhibitors, HER2 inhibitors. There is positive evidence of human fetal risk during pregnancy. Tykerb 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Tykerb 250 mg GS XJG
Tykerb 250 mg GS XJG
Discount Card Promo
Tykerb
Generic Name:
lapatinib
Imprint:
GS XJG
Strength:
250 mg
Color:
Orange
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
EGFR inhibitors
HER2 inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
GlaxoSmithKline
National Drug Code (NDC):
00173-0752
Inactive Ingredients:
magnesium stearate
microcrystalline cellulose
povidone
sodium starch glycolate type A potato
FD&C Yellow No. 6
hypromelloses
polyethylene glycol
polysorbate 80
titanium dioxide

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide